Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. NVDA
5. USO
6. META
7. AMC
8. AMD
9. NUAI
10. MSFT

Go back to Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Delayed: 9.13 +0.07 (0.77%)
Previous Close $9.06    52 Week High $5.40 
Open $9.14    52 Week Low $1.88 
Day High $9.28    P/E N/A 
Day Low $8.93    EPS $0.00 
Volume 633,883